COVID-19 Blog
- All
- Centers for Disease Control & Prevention
- Centers for Medicare and Medicaid Services
- Chicago Department of Public Health
- Chicago Medical Society
- Government Agencies
- Illinois Department of Public Health
- Illinois State Medical Society
- Media
- Medical Organizations
- State of Illinois
Centers for Disease Control & Prevention
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
Excerpt…
The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States. Both vaccines are lipid nanoparticle-formulated, nucleoside-modified mRNA vaccines encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19.